Clorox (CLX) Change in Receivables (2009 - 2026)

Clorox's Change in Receivables history runs 17 years deep, the most recent figure standing at -$2.0 million for Q1 2026.

• On a quarterly basis, Change in Receivables rose 71.43% year-over-year to -$2.0 million in Q1 2026; TTM through Mar 2026 was $58.0 million, a 209.43% increase from a year earlier, with the FY2025 full-year figure at $145.0 million, up 326.47% from the prior year.
• Change in Receivables climbed to -$2.0 million in Q1 2026 per CLX's latest filing, from -$38.0 million in the prior quarter.
• Across five years, Change in Receivables topped out at $216.0 million in Q2 2025 and bottomed at -$118.0 million in Q3 2025.
• The 5-year median for Change in Receivables is $12.0 million (2023), against an average of $8.8 million.
• Biggest YoY gain for Change in Receivables was 1100.0% in 2025; the steepest drop was 290.0% in 2025.
• Year by year, Change in Receivables stood at -$15.0 million in 2022, then surged by 720.0% to $93.0 million in 2023, then sank by 78.49% to $20.0 million in 2024, then sank by 290.0% to -$38.0 million in 2025, then jumped by 94.74% to -$2.0 million in 2026.
• Per Business Quant, the three latest CLX Change in Receivables figures stand at -$2.0 million (Q1 2026), -$38.0 million (Q4 2025), and -$118.0 million (Q3 2025).